The Purpose of Epidemiological Studies in Myasthenia Gravis Explored
Epidemiological studies for rare diseases such as myasthenia gravis are important for both the physician and the policymaker.
Epidemiological studies for rare diseases such as myasthenia gravis are important for both the physician and the policymaker.
Patients with myasthenia gravis are vulnerable to myocardial injury. However, this condition often goes undetected and untreated.
Myasthenia gravis is a neuromuscular disorder driven by autoimmunity against the postsynaptic neuromuscular junction of skeletal muscles. The clinical manifestations of myasthenia gravis are broad, but generally it can be characterized as being fluctuating, chronic, and oftentimes carrying a poor prognosis. “[Myasthenia gravis] impairs [neuromuscular junction] transmission and can manifest in a spectrum ranging from…
The parental burden of care of children with rare diseases is considerable and deserves due attention and support.
Myasthenia gravis is a multisystem autoimmune disease that results in fatigable muscle weakness. There are various classes of the disease depending on its severity. In mild cases, only the extraocular muscles are involved; in severe cases, the throat and respiratory muscles are involved, leading to breathing difficulties. Among the lesser known symptoms of myasthenia gravis…
Myasthenia gravis has been associated with poorer sleep, poorer quality of life, and a higher rate of anxiety and depression.
During the height of the COVID-19 pandemic, physicians reported treating new cases of myasthenia gravis post-infection.
Picture for a moment living with this set of symptoms on a daily basis—how would you like your physician to respond?
Researchers proposed a 4-item test to detect signs of bulbar and respiratory involvement when treating patients with myasthenia gravis remotely.
We examine the lasting impact of innovative clinical trial designs for rare diseases on other clinical experiments.